ArticleInternational cancer conference journal2016
Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Toshiaki Saeki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.